SGLT2 INHIBITORS

Clinical trials for SGLT2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Heart attack survivors may benefit from diabetes drug, new study suggests

Disease control Not yet recruiting

This study tests whether dapagliflozin, a drug typically used for diabetes, can reduce inflammation in the heart arteries of people who have had a heart attack but do not have diabetes or heart failure. About 110 participants will receive either the drug plus standard care or sta…

Matched conditions: SGLT2 INHIBITORS

Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

SGLT2 INHIBITORS

Get alerted when new SGLT2 INHIBITORS trials appear

Heart attack survivors may benefit from diabetes drug, new study suggests